In the STING agonist-treated tumour-bearing mice, we foundsignificantly elevated levels of the cytokines, CXCL10, CCL5, IFN-γ, M-CSF, CXCL9and CXCL1 at early, mid and late time points in comparison to levels in plasmafrom vehicle-treated mice (Fig. 5). The gene discussed is STING1; the disease is neoplasm.